Cold Chain Break at a Kandhamal Outreach Session
A health worker reaches a remote village in Kandhamal district with a cold box containing 200 doses of measles–rubella (MR) vaccine, 100 doses of hepatitis B vaccine, and 50 doses of DPT. The cold box was packed the previous evening with conditioned ice packs. A power cut at the sub-centre lasted 9 hours; the vaccine vial monitor (VVM) on the MR vials is at stage 2 (the inner square is darker than the outer circle but not completely dark). The hepatitis B vials have a VVM at stage 1 but the temperature logger in the cold box shows the box was exposed to +14°C for 6 hours. The DPT vials were beside the ice packs and show a shake test result that is milky, with sediment settling slowly. The session is today and 60 children are expected. The district store can resupply in 48 hours. The health worker must decide what to use and what to discard, and document the decision.
1. Decide whether to use or discard each vaccine and justify the decision using the VVM, shake test, and heat/freeze stability.
Read the worked answer
MR vaccine: use it. The VVM is at stage 2, which is still before the discard point; the VVM integrates cumulative heat exposure. MR is heat-sensitive but is a freeze-dried vaccine, and +14°C for 6 hours is not a reason to discard when the VVM remains at stage 2. Check expiry and reconstitute only with the correct diluent.
Hepatitis B vaccine: the VVM is at stage 1 and the logger shows +14°C, not freezing, so heat exposure is acceptable. Hepatitis B is freeze-sensitive, but no freezing is recorded. Use it if the vials are intact and within expiry; if freezing is suspected, perform a shake test against a known non-frozen control.
DPT vaccine: DPT is freeze-sensitive. A milky appearance with slow-settling sediment is suspicious, but the shake test must be compared with a control. If the suspect vial clears more slowly or has granular clumps that do not disperse like the control, discard it. Do not use a vial that fails the shake test. If in doubt, discard, because freeze-damaged DPT can cause local reactions and has reduced potency.
2. How would your decisions change if the cold box had reached 0°C and ice had formed around the vials?
Read the worked answer
The decisions would separate by freeze sensitivity, not by VVM alone. MR vaccine is freeze-dried and is not damaged by freezing before reconstitution, so the MR vials could still be used if the VVM remains at stage 1 or 2 and the vials are intact; freezing is not the limiting factor for MR. Hepatitis B and DPT are freeze-sensitive: freezing can cause adjuvant aggregation, reducing potency and increasing local reactions. If ice formed around those vials, discard them, even if the VVM is at stage 1, because the VVM does not detect freezing. A shake test can support the decision but is not a substitute for avoiding a known freeze. The health worker should record the freezing event, request resupply, and use the MR doses for the session while postponing hepatitis B and DPT until replacement arrives. This is why freeze indicators and proper ice-pack conditioning matter.
3. What documentation and system fixes should follow this session?
Read the worked answer
Record lot numbers, expiry dates, VVM stages, temperature logger data, shake test results, doses used, doses discarded and the reason for each discard. Inform the district immunisation officer the same day and request replacement stock. Review why the power cut lasted 9 hours and whether a backup fridge, solar direct-drive refrigerator or a second cold box is needed. Retrain on conditioning ice packs so they do not freeze vaccines, and on packing the cold box with a temperature logger and freeze indicator. Display a simple decision chart: VVM stage 1 or 2 is usable; stage 3 or beyond is discard; freeze-sensitive vaccines that have been frozen are discard. Do not use opened multi-dose vials beyond the allowed session policy. Finally, audit the session after 48 hours to confirm that no discarded vaccine was used and that resupply reached the village.